Minireviews
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Jan 27, 2016; 8(1): 84-89
Published online Jan 27, 2016. doi: 10.4240/wjgs.v8.i1.84
Table 2 Surgeons’ treatment preferences in different clinical scenarios (Suen et al[8])
Clinical scenariosLevel of clinical certainty
Evidence of community equipoise?
Surgery (%)Undecided (%)Stent (%)
170yo; partial obstruction; metastatic cancer; ASA score 481280N
270yo; complete obstruction; metastatic cancer; ASA 49882N
350yo; partial obstruction; metastatic cancer; ASA 4151075N
450yo; complete obstruction; metastatic cancer; ASA 412880N
570yo; partial obstruction; metastatic cancer; ASA 1511930Y
670yo; complete obstruction; metastatic cancer; ASA 1401347Y
750yo; partial obstruction; metastatic cancer; ASA 1601723Y
850yo; complete obstruction; metastatic cancer; ASA 1511435Y
970yo; partial obstruction; curable cancer; ASA 4661519Y
1070yo; complete obstruction; curable cancer; ASA 4411346Y
1150yo; partial obstruction; curable cancer; ASA 4731017N
1250yo; complete obstruction; curable cancer; ASA 4501139Y
1370yo; partial obstruction; curable cancer; ASA 19640N
1470yo; complete obstruction; curable cancer; ASA 179129N
1550yo; partial obstruction; curable cancer; ASA 19640N
1650yo; complete obstruction; curable cancer; ASA 18794N